Skip to main content
logo
Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
64.04
+0.04 (0.06%)
At close: Sep 11, 2025, 4:00 PM EDT
62.86
-1.18 (-1.84%)
After-hours: Sep 11, 2025, 7:06 PM EDT

Ionis Pharmaceuticals Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
603.82M407.74M412.20M517.20M519.24M476.54M479.40M305.40M
Research and Development Growth
16.29%-14.44%-14.02%69.35%56.10%71.59%68.45%-46.00%
Commercial
340.66M309.94M293.36M286.36M294.71M300.57M308.75M309.75M
Commercial Growth
15.59%3.12%-4.98%-7.55%-1.13%0.74%1.94%-0.04%

Revenue by Product

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Spinraza
223.56M225.96M216.41M214.41M224.45M228.72M240.51M245.51M
Spinraza Growth
-0.40%-1.21%-10.02%-12.67%-6.44%-4.11%-0.65%0.58%
Tegsedi and Waylivra
36.17M30.83M33.74M34.74M34.11M36.57M34.42M32.42M
Tegsedi and Waylivra Growth
6.05%-15.69%-1.96%7.17%13.49%22.78%16.81%3.03%
Wainua
35.16M28.52M20.28M----------------
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.